PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

🧠 Clinical library

Clinical Specialty Index

623 articles indexed across 24 specialties, each reviewed by a licensed pharmacist before publication.

Showing 90 from 1 topic.Sort: Newest | Oldest
Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer: Survival Benefit Varies by Setting
Analysis Oncology Pharmacy Confirmatory Grade: Moderate

PD-1/PD-L1 inhibitors boost survival in triple-negative breast cancer.

Real-World Data Favor ARIs Over Abiraterone in Metastatic Hormone-Sensitive Prostate Cancer
Analysis Oncology Pharmacy Hypothesis-generating Grade: Low

Androgen receptor inhibitors show longer survival in prostate cancer.

Ivonescimab Plus Chemotherapy for Post-Escalation EGFR-Mutated NSCLC Leptomeningeal Metastases: Retrospective Signal
Analysis Oncology Pharmacy Hypothesis-generating Grade: Very Low

Exploring ivonescimab as salvage therapy for advanced NSCLC challenges.

One in Four Carboplatin Shortage Allocations Missed Policy Intent
★ Must Read Analysis Oncology Pharmacy Hypothesis-generating Grade: Low
Also in Clinical Practice

Addressing chemotherapy shortages reveals critical allocation policy gaps.

Chemotherapy-Free Ponatinib-Blinatumomab Beats Imatinib-Chemotherapy in Adult Ph-Positive ALL
★ Editor's Pick Analysis Oncology Pharmacy Practice-changing Grade: Moderate

Chemotherapy-free regimen improves survival in Ph-positive ALL.

ARPI Intensification Raises Any-Grade Neutropenia Modestly, Not Severe Neutropenia
Analysis Oncology Pharmacy Confirmatory Grade: Low

ARPI intensification in prostate cancer modestly boosts neutropenia risk.

Perioperative chemoimmunotherapy improves survival in resectable gastric cancer
Analysis Oncology Pharmacy Confirmatory Grade: High

ICI plus chemotherapy boosts survival in gastric cancer treatment.

Adding Bevacizumab to Chemoimmunotherapy Extends PFS in Liver-Metastatic Lung Adenocarcinoma
Analysis Oncology Pharmacy Hypothesis-generating Grade: Low

New treatments show promise for liver metastases in lung cancer.

Thymosin Alpha-1 Plus Chemotherapy in Gastric Cancer: Short-Term Gains, Weak Evidence
Analysis Oncology Pharmacy Hypothesis-generating Grade: Low

Thymosin alpha-1 boosts chemotherapy efficacy and safety in gastric cancer.

Chronic irAEs Persist in Nearly Half of Adjuvant Anti-PD-1 Melanoma Patients
Analysis Oncology Pharmacy Hypothesis-generating Grade: Low

Chronic irAEs affect nearly half of melanoma patients on anti-PD-1 therapy.

Pharmacist Telemedicine Partially Offset Palliative Access Loss During Oncology Clinic Staffing Shortage
Analysis Palliative Care Hypothesis-generating Grade: Very Low
Also in Oncology

Pharmacists drive telemedicine to bridge palliative care gaps.

Giredestrant Plus Everolimus Extends Post-CDK4/6 Inhibitor PFS, Driven by ESR1 Mutations
Analysis Oncology Pharmacy Practice-changing Grade: Moderate

Giredestrant boosts outcomes in resistant breast cancer.

Metronomic Chemotherapy Extends PFS After CDK4/6 Inhibitor Progression
Analysis Oncology Pharmacy Hypothesis-generating Grade: Low

Metronomic chemotherapy improves progression-free survival in difficult-to-treat breast cancer.

Targeting Leukemia Stem Cells to Expand Treatment-Free Remission in CML
Analysis Oncology Pharmacy Hypothesis-generating Grade: Very Low

Novel therapies for CML aim to overcome resistance and improve remission.

Pharmacist Counseling Cuts Chemotherapy Admissions in Single-Center QI Study
Analysis Oncology Pharmacy Hypothesis-generating Grade: Low
Also in Clinical Practice

Pharmacist-led counseling slashes chemo admissions and boosts satisfaction.